During the past decade, OptumCare Cancer Care conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "OptumCare Cancer Care" #1 sponsor was "BioAtla, Inc." with 2 trials, followed by "NovoCure GmbH" with 2 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Tempus Labs" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "OptumCare Cancer Care" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "OptumCare Cancer Care" are "Head and Neck Cancer" (2 trials), "Melanoma" (2 trials), "Non-small Cell Lung Cancer" (2 trials), "Breast Tumor" (1 trials) and "Colon Tumor, Malignant" (1 trials). Many other conditions were trialed in "OptumCare Cancer Care" in a lesser frequency.

Most popular intervention types in "OptumCare Cancer Care" are "Drug" (4 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "NovoTTF-200T" (2 trials), "PD-1 inhibitor" (2 trials), "Abemaciclib" (1 trials), "CAB-AXL-ADC" (1 trials) and "CAB-ROR2-ADC" (1 trials). Other intervention names were less common.

The vast majority of trials in "OptumCare Cancer Care" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "OptumCare Cancer Care". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in OptumCare Cancer Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in OptumCare Cancer Care, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".